Efficacy and safety of biologic therapies for chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis
Biologic therapies targeting IgE, IL-5/IL-5Rα, and TSLP produce clinically meaningful, statistically significant improvements in nasal polyp size and sinonasal quality of life compared with placebo in patients with CRSwNP, although the magnitude of effect varies substantially by mechanism and population.